We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$115B
1-Year Est. Return
41.58%
This Fund
S&P 500
This Quarter
Est. Return
+9.35%
1 Year Est. Return
+41.58%
3 Year Est. Return
+119.77%
5 Year Est. Return
+143.7%
10 Year Est. Return
+448.76%
AUM
$72.1B
AUM Growth
+$1.8B
(+2.6%)
Cap. Flow
-$3.77B
Cap. Flow
% of AUM
-5.22%
Top 10 Holdings %
Top 10 Hldgs %
26.35%
Holding
1,433
New
113
Increased
705
Reduced
392
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
|
+$105M |
| 2 |
TSMC
TSM
|
+$103M |
| 3 |
Amazon
AMZN
|
+$99.2M |
| 4 |
Match Group
MTCH
|
+$92M |
| 5 |
SPDR Gold Trust
GLD
|
+$70.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royal Bank of Canada
RY
|
+$490M |
| 2 |
Toronto Dominion Bank
TD
|
+$411M |
| 3 |
Scotiabank
BNS
|
+$359M |
| 4 |
Enbridge
ENB
|
+$281M |
| 5 |
Canadian National Railway
CNI
|
+$259M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.06% |
| 2 | Technology | 15.4% |
| 3 | Healthcare | 9.1% |
| 4 | Industrials | 8.83% |
| 5 | Communication Services | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Schrodinger
SDGR
$1.17B
| $803K | ﹤0.01% |
16,909
| – | – |
|
|
GBIO
1127
DELISTED
Generation Bio
GBIO
| $798K | ﹤0.01% |
2,582
+230
| +10% | +$55K |
|
1128
Harmony Biosciences
HRMY
$2.25B
| $798K | ﹤0.01% |
+23,544
| New | +$858K |
|
1129
Old Republic International
ORI
$10.5B
| $798K | ﹤0.01% |
54,125
| – | – |
|
1130
Scholar Rock
SRRK
$5.73B
| $783K | ﹤0.01% |
44,275
+21,860
| +98% | +$325K |
|
1131
Crown Holdings
CCK
$13.2B
| $782K | ﹤0.01% |
+10,179
| New | +$745K |
|
1132
Keurig Dr Pepper
KDP
$42.3B
| $781K | ﹤0.01% |
+28,302
| New | +$829K |
|
1133
Relay Therapeutics
RLAY
$4.26B
| $781K | ﹤0.01% |
+18,340
| New | +$699K |
|
1134
Melco Resorts & Entertainment
MLCO
$2.17B
| $774K | ﹤0.01% |
46,491
+491
| +1% | +$8.7K |
|
1135
Cytokinetics
CYTK
$10.7B
| $773K | ﹤0.01% |
+35,700
| New | +$835K |
|
1136
Intellia Therapeutics
NTLA
$1.58B
| $772K | ﹤0.01% |
38,857
+4,300
| +12% | +$89.7K |
|
1137
Zscaler
ZS
$26.4B
| $770K | ﹤0.01% |
+5,470
| New | +$710K |
|
1138
Protagonist Therapeutics
PTGX
$8.73B
| $769K | ﹤0.01% |
39,353
| – | – |
|
|
PRFT
1139
DELISTED
Perficient Inc
PRFT
| $769K | ﹤0.01% |
18,000
-16,600
| -48% | -$669K |
|
1140
Arcturus Therapeutics
ARCT
$177M
| $768K | ﹤0.01% |
17,911
| – | – |
|
1141
Semtech
SMTC
$12B
| $768K | ﹤0.01% |
14,500
| – | – |
|
1142
iShares China Large-Cap ETF
FXI
$4.33B
| $766K | ﹤0.01% |
18,229
+11,585
| +174% | +$498K |
|
|
AKUS
1143
DELISTED
Akouos Inc
AKUS
| $758K | ﹤0.01% |
33,154
| – | – |
|
1144
Stoke Therapeutics
STOK
$1.97B
| $746K | ﹤0.01% |
22,279
| – | – |
|
1145
PG&E
PCG
$38.4B
| $744K | ﹤0.01% |
+79,200
| New | +$734K |
|
1146
Pinduoduo
PDD
$130B
| $742K | ﹤0.01% |
+10,000
| New | +$857K |
|
1147
Onto Innovation
ONTO
$14.3B
| $735K | ﹤0.01% |
24,694
-51,400
| -68% | -$1.7M |
|
1148
Zentalis Pharmaceuticals
ZNTL
$347M
| $735K | ﹤0.01% |
22,493
| – | – |
|
1149
Preferred Bank
PFBC
$1.27B
| $732K | ﹤0.01% |
22,800
+1,600
| +8% | +$59.8K |
|
|
FBMS
1150
DELISTED
The First Bancshares, Inc.
FBMS
| $731K | ﹤0.01% |
34,871
| – | – |
|
Similar funds
VAM
TD Asset Management's Q3 2020 Portfolio in Review
As of Q3 2020, TD Asset Management held 1,433 positions worth $72.1B, up 2.6% from $70.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
TD Asset Management withdrew a net $3.77B in Q3 2020, closing 81 positions and reducing 392 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $44.9M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 21% a quarter earlier, followed by Technology and Healthcare.
Against the trend, TD Asset Management opened a new position in State Street Consumer Staples Select Sector SPDR ETF worth $38.9M.
- TD Asset Management's largest Q3 2020 buy was State Street Consumer Staples Select Sector SPDR ETF: 607,194 shares worth $38.9M.
- TD Asset Management added most to Xtrackers Harvest CSI 300 China A-Shares ETF in Q3 2020, an estimated $105M increase.
- TD Asset Management's biggest Q3 2020 reduction was Royal Bank of Canada, cutting an estimated $490M.
- TD Asset Management fully exited Seagen Inc. Common Stock in Q3 2020, selling an estimated $44.9M.
- TD Asset Management's ten largest holdings make up 26% of its $72.1B portfolio in Q3 2020.
- TD Asset Management opened 113 new positions and closed 81 in Q3 2020.
- TD Asset Management's portfolio value rose 2.6% quarter-over-quarter to $72.1B.
Based on TD Asset Management's 13F filing for Q3 2020, filed 10 Nov 2020.